Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Atea Pharma’s Investigational Dengue Treatment Fast Tracked In US
The FDA has granted Fast Track Designation for Atea Pharmaceuticals Inc’s (NASDAQ:AVIR) AT-752 for treating dengue virus infection. AT-752, a novel, orally…
Recap: Atea Pharmaceuticals Q2 Earnings
Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Short Volatility Alert: Atea Pharmaceuticals
On Tuesday, shares of Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) experienced volatile short activity. After the activity, the stock price went down -1.73% to $7.38.
The overall sentiment for AVIR has been Bullish.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
How To Attend Atea Pharmaceuticals Q1 2022 Earnings Conference Call
Atea Pharmaceuticals (NASDAQ:AVIR) will host a conference call at 10:00 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.